AstraZeneca (AZN) Insider Trading & Ownership £116.06 -90.00 (-0.77%) (As of 10/25/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability AstraZeneca (LON:AZN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.04%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)£153,685.30Number OfInsiders Selling(Last 12 Months)0 Get AZN Insider Trade Alerts Want to know when executives and insiders are buying or selling AstraZeneca stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AZN Insider Buying and Selling by Quarter Ad Stansberry ResearchPutin proposes new currencyRussian leader Vladimir Putin just unveiled the first physical mockup of a proposed new currency. Many speculate it will be backed by gold. One thing's for sure: If it becomes reality... it could be the biggest catalyst for gold we've ever seen.Click here for full details. AstraZeneca Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/13/2024Michel DemareInsiderBuy2,000GBX 118£2,36012/12/2023Anna ManzInsiderBuy487£101.90£49,625.3011/22/2023Michel DemareInsiderBuy1,000£101.70£101,700 (Data available from 1/1/2013 forward) AZN Insider Trading Activity - Frequently Asked Questions Who is on AstraZeneca's Insider Roster? The list of insiders at AstraZeneca includes Anna Manz, and Michel Demare. Learn more on insiders at AZN. What percentage of AstraZeneca stock is owned by insiders? 0.04% of AstraZeneca stock is owned by insiders. Learn more on AZN's insider holdings. Which AstraZeneca insiders have been buying company stock? The following insiders have purchased AZN shares in the last 24 months: Anna Manz (£49,625.30), and Michel Demare (£338,080). How much insider buying is happening at AstraZeneca? Insiders have purchased a total of 5,487 AZN shares in the last 24 months for a total of £387,705.30 bought. More Insider Trading Tools from MarketBeat Related Companies GSK Insider Selling Grainger Insider Selling Ithaca Energy Insider Selling Indivior Insider Selling Bloomsbury Publishing Insider Selling India Capital Growth Insider Selling Pharos Energy Insider Selling Alpha Real Trust Insider Selling Marks Electrical Group Insider Selling Revolution Beauty Group Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideInsiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 Stocks This page (LON:AZN) was last updated on 10/26/2024 by MarketBeat.com Staff From Our PartnersAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored“Hear That Whoosh Sound? It’s the Great Power Suck of 2025”We’re coming to the end of the line for the traditional energy grid. Look what’s happening in California.Traders Agency | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredPutin proposes new currencyRussian leader Vladimir Putin just unveiled the first physical mockup of a proposed new currency. Many spec...Stansberry Research | SponsoredONE crypto stock +526% in under 60 daysCryptos are screaming higher right now. Yet, this ONE started a shooting up a little under 60 days ago.The Bitcoin Capitalist | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.